LungLife AI Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:LLAI Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
14 Aug 23	BuyUK£8,467	David Anderson	Individual		12,123	UK£0.70
14 Aug 23	BuyUK£8,467	Paul Pagano	Individual		12,123	UK£0.70

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.3%.

Top 17 shareholders own 75.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.5%	Simon Raab	4,148,293	UK£788.2k	0%	no data
12.7%	Unicorn Asset Management Ltd.	3,907,142	UK£742.4k	123%	0.11%
8.06%	Mount Sinai School Of Medicine, Endowment Arm	2,469,842	UK£469.3k	0%	0.66%
6.42%	Octopus Investments Limited	1,968,750	UK£374.1k	0%	0.02%
5.46%	Syno Capital	1,673,668	UK£318.0k	0%	no data
4.99%	Frederick Gluck	1,530,596	UK£290.8k	0%	no data
4.65%	Stifel Asset Management Corp.	1,424,784	UK£270.7k	10.9%	no data
4.55%	Investec Wealth & Investment Limited	1,394,839	UK£265.0k	10.2%	no data
4.4%	Bohai Ferry Group Co., Ltd.	1,347,653	UK£256.1k	0%	no data
4.14%	Lombard Odier	1,268,363	UK£241.0k	0%	no data
3.11%	Huateng Ma	954,048	UK£181.3k	0%	no data
2.73%	Killik Asset Management	836,964	UK£159.0k	-19.7%	0.01%
0.71%	SVM Asset Management Ltd.	218,750	UK£41.6k	0%	0.01%
0.14%	Roy Davis	42,775	UK£8.1k	201%	no data
0.086%	Paul Pagano	26,408	UK£5.0k	118%	no data
0.086%	David Anderson	26,408	UK£5.0k	118%	no data
0.065%	Andrew Boteler	19,966	UK£3.8k	251%	no data